Mark McClellan, Duke-Margolis Center for Health Policy
Duke to host private meeting with payers and biopharma on how to pay for Alzheimer's drugs
How is the US going to restrict the use of Biogen’s new Alzheimer’s drug so Medicare doesn’t go bankrupt before the end of the decade …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
